Cytk earnings

Author: nikh

August undefined, 2024

WebJun-24-22 08:44AM. Shareholders have faith in loss-making Cytokinetics (NASDAQ:CYTK) as stock climbs 20% in past week, taking three-year gain to 329%. Simply Wall St. 07:30AM. Cytokinetics Announces Date for FDA Advisory Committee Meeting to Review New Drug Application for Omecamtiv Mecarbil. GlobeNewswire. WebMar 2, 2024 · Press Release. EPS of -$1.45 misses by $0.24 Revenue of $1.96M (-96.48% Y/Y) misses by $4.51M. Cytokinetics, Incorporated ( NASDAQ: CYTK) Q4 2024 …

Cytokinetics, Incorporated (CYTK) Earnings Report Seeking Alpha

WebNov 4, 2024 · CYTK earnings call for the period ending September 30, 2024. Image source: The Motley Fool. Cytokinetics, Incorporated ( CYTK -0.80%) Q3 2024 Earnings Call. Nov 3, 2024, 4:30 p.m. ET. Web18 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Cytokinetics (CYTK) rattlesnake\u0027s 0b

CYTK Cytokinetics Inc. Stock Price & News - WSJ

WebApr 13, 2024 · Analyst price target for CYTK is US$60.06, which is 58% above our fair value estimate. ... Debt is well covered by earnings. Weakness. Shareholders have been diluted in the past year. WebFeb 22, 2024 · Zacks Consensus Estimate This biopharmaceutical company is expected to post quarterly loss of $1.22 per share in its upcoming report, which represents a year-over-year change of -238.9%. Revenues... WebApr 9, 2024 · The company has a market capitalization of $3.48 billion, a price-to-earnings ratio of -8.57 and a beta of 0.80. Cytokinetics, Incorporated has a 12-month low of $32.96 and a 12-month high of $55.80. dr srećko sladoljev

Cytokinetics, Incorporated (CYTK) - Stock Analysis

Cytk earnings

CYTK Cytokinetics Inc. Analyst Estimates MarketWatch

WebApr 10, 2024 · Cytokinetics (CYTK) ... In the past 30 days, estimates for Novo Nordisk’s 2024 earnings per share have risen from $4.20 to $4.43 and estimates for 2024 have … WebApr 10, 2024 · In the past 30 days, estimates for Novo Nordisk’s 2024 earnings per share have risen from $4.20 to $4.43 and estimates for 2024 have gone up by 29 cents to $5.19.

Did you know?

Web12 hours ago · Cytokinetics (CYTK) In a report released yesterday, Madhu Kumar from Goldman Sachs maintained a Buy rating on Cytokinetics. The company’s shares closed … Web2 days ago · Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates. Cytokinetics (CYTK) delivered earnings and revenue surprises of -18.85% and 73.77%, …

Web8 rows · CYTK: Raising target price to $38.00CYTOKINETICS INC has an Investment Rating of HOLD; a target ... WebCYTK Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list Create CYTK Alert Open Last Updated: Sep 16, …

WebApr 10, 2024 · Cytokinetics (CYTK) ... In the past 30 days, estimates for Novo Nordisk’s 2024 earnings per share have risen from $4.20 to $4.43 and estimates for 2024 have gone up by 29 cents to $5.19. WebApr 6, 2024 · Cytokinetics, Incorporated (CYTK) latest earnings report: revenue, EPS, surprise, history, news and analysis.

WebCytokinetics (CYTK) delivered earnings and revenue surprises of -18.85% and 73.77%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? CYTK : 37.50 (+6.56%) LQDA : 7.00 (+1.30%) Cytokinetics: Q4 Earnings Snapshot AP - Wed Mar 1, 3:34PM CST Cytokinetics: Q4 Earnings Snapshot

WebApr 12, 2024 · Cytokinetics (NASDAQ:CYTK – Get Rating) last posted its earnings results on Wednesday, March 1st. The biopharmaceutical company reported ($1.45) earnings per share (EPS) for the quarter, missing ... dr sreejith manjeriWebThe technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a … dr. sree bhavani chalasani dr. sreedevi rama mdWebCytokinetics (CYTK) will release its next earnings report on May 11, 2024. In the last quarter Cytokinetics reported -$1.206 EPS in relation to -$1.45 expected by the market. rattlesnake\\u0027s 0cWebApr 6, 2024 · Cytokinetics started at overweight with $58 stock price target at J.P. Morgan. Dec. 10, 2024 at 6:59 a.m. ET by Tomi Kilgore. Biotech and Pharma Cytokinetics Stock … rattlesnake\u0027s 0aWebMar 1, 2024 · Cytokinetics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.96 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by... rattlesnake\u0027s 0cWebApr 6, 2024 · Cytokinetics, Incorporated (CYTK) latest earnings report: revenue, EPS, surprise, history, news and analysis. dr sreekanth kodur